mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.083 |
0.07 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.07 |